Press Releases
Cyxone receives Intention to Grant from the European Patent Office for the divisional patent of T20K
31 May, 2023 14:00 CESTBulletin from the annual general meeting in Cyxone AB on 30 May 2023
30 May, 2023 11:00 CESTRegulatoryInterim Report 1 January to 31 March 2023
12 May, 2023 08:22 CESTRegulatoryCyxone receives patent approval from the US for the salt forms of the compound rabeximod
9 May, 2023 13:45 CESTRegulatoryAnnual Report from Cyxone AB for the period 1 January 2022 to 31 December 2022
27 Apr, 2023 13:03 CESTRegulatory